Ling Lin

机构：Sir Run Run Shaw Hospital · ORCID：0000-0002-6446-1944

发表论文 40 篇 · 总被引 845 次 · h-index 11

代表论文

• Nano drug delivery systems for advanced immune checkpoint blockade therapy (2025 · Theranostics · 被引 121)
• Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity (2023 · Advanced Materials · 被引 103)
• An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy (2024 · ACS Nano · 被引 54)
• Atomic‐Scale View of Protein‐PEG Interactions that Redirect the Thermal Unfolding Pathway of PEGylated Human Galectin‐3 (2022 · Angewandte Chemie International Edition · 被引 9)
• Proteomics analysis reveals the importance of transcriptional regulator slyA in regulation of several physiological functions in Aeromonas hydrophila (2021 · Journal of Proteomics · 被引 9)
• Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques (2023 · International Immunopharmacology · 被引 6)